Galohgor Nutraceutical Supplementation Reduces Fasting Blood Glucose: A Pre-Post-Controlled Trial in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.65763/jfhb.2026.e269842Keywords:
Type 2 diabetes mellitus, Galohgor, Indonesia, Nutraceuticals, Fasting blood glucoseAbstract
Galohgor nutraceutical (GN) is a polyherbal product from the Sundanese ethnic group in Indonesia. GN contains antioxidants and other bioactive compounds that have shown synergistic effects in controlling blood glucose in animal models and significantly decreasing oxidative stress in patients with Type 2 Diabetes Mellitus (T2DM). The aim of this study was to analyze the effect of GN on the fasting blood glucose (FBG) levels of T2DM subjects. A quasi-experimental pre-post-controlled trial design was conducted with 26 subjects divided into two groups: intervention and control. One subject from the control group and 6 from the GN group were excluded due to illness or voluntary withdrawal. The study was conducted in the Bogor District, West Java, over a 38-day intervention period. The formulation of the GN cookies and powdered drinks in the intervention group was similar to the control group, but supplemented with 2 g of GN powder daily, which was added in 24 g of cookies (containing 1 g of GN/serving size) and one pack of powdered drinks (containing 1 g of GN/serving size). The study received ethical approval (No.422/III/LPPM-PM.10.05/05/2016). Physical activity was measured using the International Physical Activity Questionnaire (IPAQ). Food intake data were obtained via a 24-h food record and recall combination at the beginning and during the intervention. The frequency of high glycemic index (GI) carbohydrate consumption was measured using a semi-quantitative food frequency questionnaire (SQ-FFQ). Differences in FBG between groups were tested using ANCOVA. At baseline, the FBG levels of the GN intervention and control groups were 267.5 mg/dL and 241.5 mg/dL, respectively. FBG significantly decreased in the GN intervention group compared to the control group (p<0.015). This study was limited by its quasi-experimental pre-post design and small sample size which may have introduced selection bias and limited generalizability. To elaborate on the potential effects and mechanisms of GN as an antidiabetic agent, further studies should be conducted with larger, randomized T2DM cohorts using standardized GN products.
References
Arif, S., Isdijoso, W., Fatah, A.R., & Tamyis, A.R. (2020). Strategic review of food security and nutrition in Indonesia: 2019–2020 update. The SMERU Research Institute.
Atkinson, F.S., Brand-Miller, J.C., Foster-Powell, K., Buyken, A.E., & Goletzke, J. (2021). International tables of glycemic index and glycemic load values 2021: A systematic review. The American Journal of Clinical Nutrition, 114(5), 1625–1632. https://doi.org/10.1093/ajcn/nqab233
Brand-Miller, J., Hayne, S., Petocz, P., & Colagiuri, S. (2003). Low–glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care, 26(8), 2261–2267. https://doi.org/10.2337/diacare.26.8.2261
Carvalho, K.M.M.B., Morais, T.C., de Melo, T.S., de Castro Brito, G.A., de Andrade, G.M., Rao, V.S., & Santos, F.A. (2010). The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice. Biological and Pharmaceutical Bulletin, 33(9), 1534–1539. https://doi.org/10.1248/bpb.33.1534
Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M.P., Salvatore, T., ... Sasso, F.C. (2023). Oxidative stress in type 2 diabetes: Impacts from pathogenesis to lifestyle modifications. Current Issues in Molecular Biology, 45(8), 6651–6666. https://doi.org/10.3390/cimb45080420
Damayati, E., Roosita, K., & Sulaeman, A. (2018). Effect of galohgor cookies and powder drinks on visceral adipose tissue and lipid profile in patients with type 2 diabetes mellitus. Jurnal Gizi dan Pangan, 13(3), 137–144. https://doi.org/10.25182/jgp.2018.13.3.137-144
Firdaus, F., Rimbawan, R., Marliyati, S.A., & Roosita, K. (2016). Role of nutraceutical Galohgor in maintenance of body weight and reducing blood glucose on diabetic rats induced by streptozotocin. Jurnal Aplikasi Teknologi Pangan, 5(3), 85–88. https://doi.org/10.17728/jatp.29
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy, 4(2), 175–194. https://doi.org/10.1007/s13300-013-0034-y
Ghorbani, A. (2014). Clinical and experimental studies on polyherbal formulations for diabetes: Current status and future prospective. Journal of Integrative Medicine, 12(4), 336–345. https://doi.org/10.1016/S2095-4964(14)60031-5
Ghorbani, A., Rashidi, R., & Shafiee-Nick, R. (2019). Flavonoids for preserving pancreatic beta cell survival and function: A mechanistic review. Biomedicine & Pharmacotherapy, 111, 947–957. https://doi.org/10.1016/j.biopha.2018.12.127
Gómez‐Ambrosi, J., Silva, C., Galofré, J.C., Escalada, J., Santos, S., Gil, M.J., ... Frühbeck, G. (2011). Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI. Obesity, 19(7), 1439–1444. https://doi.org/10.1038/oby.2011.36
Hastuti, J. (2013). Anthropometry and body composition of Indonesian adults: An evaluation of body image, eating behaviours, and physical activity [Doctoral dissertation, Queensland University of Technology]. QUT ePrints. https://eprints.qut.edu.au/63737/
Indonesian Ministry of Health. (2018). Laporan nasional Riskesdas 2018 (Technical Report). National Institute of Health Research and Development. https://repository.badankebijakan.kemkes.go.id/id/eprint/3514
Johnson, E.L., Feldman, H., Butts, A., Chamberlain, J., Collins, B., Doyle-Delgado, K., … Gabbay, R.A. (2021). Standards of medical care in diabetes—2021 abridged for primary care providers. Clinical Diabetes, 39(1), 14–43. https://doi.org/10.2337/cd21-as01
Kanaley, J.A., Colberg, S.R., Corcoran, M.H., Malin, S.K., Rodriguez, N.R., Crespo, C.J., ... Zierath, J.R. (2022). Exercise/physical activity in individuals with type 2 diabetes: A consensus statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise, 54(2), 353–368. https://doi.org/10.1249/MSS.0000000000002800
Mesquita, L. de A., Wayerbacher, L.F., Schwartsmann, G., & Gerchman, F. (2023). Obesity, diabetes, and cancer: Epidemiology, pathophysiology, and potential interventions. Archives of Endocrinology and Metabolism, 67(6), e000647. https://doi.org/10.20945/2359-3997000000647
Panche, A.N., Diwan, A.D., & Chandra, S.R. (2016). Flavonoids: An overview. Journal of Nutritional Science, 5, e47. https://doi.org/10.1017/jns.2016.41
Post, R.E., Mainous, A.G., King, D.E., & Simpson, K.N. (2012). Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis. The Journal of the American Board of Family Medicine, 25(1), 16–23. https://doi.org/10.3122/jabfm.2012.01.110148
Ramesh, V., Subbarayan, K., Viswanathan, S., & Subramanian, K. (2023). Role of nutraceuticals in the management of lifestyle diseases. In D. Shankaran & R.S.V. Raghavan (Eds.), Role of herbal medicines: Delivery systems and clinical applications (pp. 461–478). Springer Nature Singapore. https://doi.org/10.1007/978-981-99-7703-1_23
Rascón-Careaga, A., Corella-Madueño, M.A.G., Pérez-Martínez, C.J., García-Rojas, A.M., Souflé-Vásquez, S.Z., García-Moroyoqui, M.T., ... García-Alegría, A.M. (2021). Validation and estimation of uncertainty for a glucose determination method GOD-PAP using a multi-calibrator as reference. MAPAN - Journal of Metrology Society of India, 36(2), 269–278. https://doi.org/10.1007/s12647-021-00441-5
Riccardi, G., Rivellese, A.A., & Giacco, R. (2008). Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. The American Journal of Clinical Nutrition, 87(1), 269S–274S. https://doi.org/10.1093/ajcn/87.1.269S
Roosita, K., Ekawidyani, K.R., Kushargina, R., Fathimah, Rafi, M., & Saepuloh, U. (2024). Modulation of gene expression by traditional Asian antidiabetic nutraceuticals: A review of potential effects. Asia Pacific Journal of Clinical Nutrition, 33(4), 512–525. https://doi.org/10.6133/apjcn.202412_33(4).0006
Roosita, K., Ma’rifah, B., Nurdin, N.M., & Anwar, F. (2022). Effects of Galohgor nutraceutical lactation cookies on breast milk volume and lactose concentration. Korean Journal of Family Medicine, 43(1), 56–62. https://doi.org/10.4082/kjfm.20.0224
Roosita, K., Sa’diah, S., Wientarsih, I., & Rohadi, R. (2014). Optimasi proses ekstraksi nutrasetikal Galohgor. In Prosiding Simposium Penelitian Bahan Obat Alami (SPBOA) XVI dan Muktamar XII PERHIBPA 2014 (pp. 112–118). PERHIBPA.
Segatto, M., Rosso, P., Fioramonti, M., Fracassi, A., Marangoni, M., Taglietti, V., & Siteni, S. (2016). AMPK in the central nervous system: Physiological roles and pathological implications. Research and Reports in Biology, 7, 1–13. https://doi.org/10.2147/RRB.S90858
Setyaningsih, S., Roosita, K., & Damayanthi, E. (2017). Effect Galohgor’s product on antioxidant activity and decreased oxidative stress. Media Kesehatan Masyarakat Indonesia, 13(4), 310–316. https://doi.org/10.30597/mkmi.v13i4.1930
Tran, N., Pham, B., & Le, L. (2020). Bioactive compounds in anti-diabetic plants: From herbal medicine to modern drug discovery. Biology, 9(9), 252. https://doi.org/10.3390/biology9090252
Utari, A., Maududi, M.S., Kusumawati, N.R.D., & Mexitalia, M. (2019). Effects of low glycemic index diet on insulin resistance among obese adolescent with non-alcoholic fatty liver disease: A randomized controlled trial. Medical Journal of Indonesia, 28(2), 123–128. https://doi.org/10.13181/mji.v28i2.2496
Wicaksono, M.A. (2010). Evaluation of liver and kidney function of female rats (Rattus norvegicus) Sprague-Dawley strain when given Galohgor herbal medicine [Undergraduate thesis, IPB University]. IPB Repository. https://repository.ipb.ac.id/handle/123456789/58811
World Health Organization. (2016). Global report on diabetes. https://iris.who.int/handle/10665/204871
Yadav, A., Kataria, M.A., Saini, V., & Yadav, A. (2013). Role of leptin and adiponectin in insulin resistance. Clinica Chimica Acta, 417, 80–84. https://doi.org/10.1016/j.cca.2012.12.007
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., ... Kadowaki, T. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8(11), 1288–1295. https://doi.org/10.1038/nm788
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., … Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7(8), 941–946. https://doi.org/10.1038/90984
Yang, H., Lin, H., Liu, X., Liu, H., Chen, T., & Jin, Z. (2024). Association between dietary fiber intake and diabetic nephropathy among adult diabetes mellitus in the United States: A cross-sectional study. Heliyon, 10(9), e30036. https://doi.org/10.1016/j.heliyon.2024.e30036
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Food Health and Bioenvironmental Science

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.




